Sponsor

Clinical trials sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Active studies whose public registry record names National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) as lead sponsor.

13active studies

10recruiting now

1countries represented

2largest site network

Current studies

Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.

Recruiting nowNot applicable

Effect of Nicotinamide Riboside on Ketosis, Fat Oxidation & Metabolic Rate

Overweight, ObesityCondition

Standard Diet, Ketogenic DietTreatment

United States1 locations

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Sponsor

Updated 2026-09-04 · NCT06044935See eligibility →

Recruiting nowNot applicable

New Heart Imaging Techniques to Evaluate Possible Heart Disease

Healthy, ObesityCondition

MR Imaging Techniques - 1, MR Imaging Techniques - 2Treatment

United States1 locations

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Sponsor

Updated 2026-09-03 · NCT01399385See eligibility →

Recruiting nowNot applicable

Physical and Behavioral Traits of Overweight and Obese Adults

Obesity, Healthy VolunteersCondition

Intervention not listedTreatment

United States1 locations

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Sponsor

Updated 2026-09-01 · NCT00428987See eligibility →

Recruiting nowNot applicable

Early Tracking of Childhood Health Determinants (ETCHED) Study

Diabetes Mellitus, ObesityCondition

Intervention not listedTreatment

United States1 locations

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Sponsor

Updated 2026-09-01 · NCT03481829See eligibility →

Recruiting nowNot applicable

Diabetes and Heart Disease Risk in Blacks

Cardiovascular Diseases, DiabetesCondition

Intervention not listedTreatment

United States1 locations

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Sponsor

Updated 2026-08-28 · NCT00001853See eligibility →

Recruiting nowNot applicable

The Effects of Increasing Caloric Intake on Diet-Induced Thermogenesis and 24h Energy Expenditure

Obesity, Normal PhysiologyCondition

+200% of dietary requirements, 50% of calories from carbohydrates, 20% from protein, and 30% from fat, fastingTreatment

United States1 locations

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Sponsor

Updated 2026-08-28 · NCT05545306See eligibility →

Recruiting nowNot applicable

Variability In Mixed Meal Tests: Fixed Versus Adjusted to Energy Needs Caloric Dose

Obesity, Healthy VolunteerCondition

Fixed Mixed Meal Test, Adjusted Mixed Meal TestTreatment

United States1 locations

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Sponsor

Updated 2026-08-18 · NCT06223555See eligibility →

Recruiting nowPhase 2

Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)

Non-Alcoholic Steatohepatitis, Non-Alcoholic Fatty Liver DiseaseCondition

SemaglutideTreatment

United States1 locations

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Sponsor

Updated 2026-08-10 · NCT03884075See eligibility →

Recruiting nowNot applicable

Youth-Onset Type 2 Diabetes and Heart Disease: The Young at Heart Prospective Cohort Study

Obesity, Type 2 DiabetesCondition

Intervention not listedTreatment

United States2 locations

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Sponsor

Updated 2026-08-05 · NCT06730113See eligibility →

Recruiting nowNot applicable

Diet Order Effects of Low Fat vs. Low Carb Diets on Body Fat Change

Overweight, ObesityCondition

Low-carbohydrate Diet, Low-fat DietTreatment

United States1 locations

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Sponsor

Updated 2026-07-31 · NCT06325722See eligibility →

Opening soonPhase 2

Trial of the Combination of Alpha-Lipoic Acid and Mirabegron in Women and in Men With Obesity

Insulin Resistance, ObesityCondition

Alpha-lipoic acid, MirabegronTreatment

United States1 locations

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Sponsor

Updated 2026-09-08 · NCT05713799See eligibility →

Opening soonNot applicable

Evaluation of the Clinical Spectrum of Diabetes and Obesity in Youth and Adults

Obesity, DiabetesCondition

Intervention not listedTreatment

United States1 locations

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Sponsor

Updated 2026-09-08 · NCT07388537See eligibility →

Active, not recruitingPhase 2

Effects of Brain Stimulation on Food Intake and Behavioral Weight Loss Treatment

Electric Stimulation Therapy, ObesityCondition

Transcranial Direct Current Stimulation (TDCS), Sham/no-stimulationTreatment

United States1 locations

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Sponsor

Updated 2026-09-01 · NCT00739362See eligibility →

Related sponsors

Novo Nordisk A/S71 Eli Lilly and Company67 University of Colorado, Denver36 Cairo University31 Mayo Clinic29 Norwegian University of Science and Technology25

How current is this page?

The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.

Does appearing here mean I qualify?

No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.